Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep;31(9):1747-1754.
doi: 10.3201/eid3109.241342.

Increased Incidence of Candida auris Colonization in Early COVID-19 Pandemic, Orange County, California, USA

Increased Incidence of Candida auris Colonization in Early COVID-19 Pandemic, Orange County, California, USA

Alissa H Dratch et al. Emerg Infect Dis. 2025 Sep.

Abstract

Candida auris transmission surged in long-term acute-care hospitals (LTACHs) in Orange County, California, USA, during the COVID-19 pandemic. This study describes the effect of COVID-19 on C. auris transmission by estimating the probability of patient colonization in LTACHs across 5 epidemiologic time periods. Patients had the highest probability of developing new skin colonization during the first COVID-19 wave, with a cumulative incidence of 22.5% (95% CI 18.5--26.6) after a 30-day stay. Once the initial COVID-19 waves abated, a reduction in cumulative incidence of C. auris colonization was observed concurrently with persistent high prevalence, indicating that within-facility transmission can be reduced with proper infection prevention and control practices. Admission screenings and point prevalence surveys provided a wealth of data that guided public health recommendations and supported the objectives of both public health professionals and LTACHs for monitoring facility transmission dynamics and guiding decision making.

Keywords: COVID-19; California; Candida auris; LTACH; United States; admission screening; competing risks; cumulative incidence; fungus; healthcare-associated infections; pandemic; point prevalence surveys; survival analysis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart showing cohort swab specimen collection and testing in study of Candida auris colonization early in the COVID-19 pandemic, Orange County, California, USA. LTACH, long-term acute-care hospital.
Figure 2
Figure 2
Seven-day moving averages of new daily COVID-19 cases in Orange County, California, USA, across 5 time periods during study of Candida auris colonization early in the COVID-19 pandemic. Black dot represents beginning of C. auris screening. Horizontal black bar represents period in which COVID vaccines first became available.
Figure 3
Figure 3
Cumulative incidence of Candida auris after 45 days of long-term acute care hospital exposure across 5 periods in study of C. auris colonization early in the COVID-19 pandemic, Orange County, California, USA. Date ranges for each study period are shown in Figure 2.
Figure 4
Figure 4
Point estimates for the cumulative incidence and median prevalence of Candida auris skin colonization in long-term acute care hospitals across 5 periods in study of C. auris colonization early in the COVID-19 pandemic, Orange County, California, USA. Date ranges for each study period are shown in Figure 2. LTACH, long-term acute-care hospital.

References

    1. Tsay S, Kallen A, Jackson BR, Chiller TM, Vallabhaneni S. Approach to the investigation and management of patients with Candida auris, an emerging multidrug-resistant yeast. Clin Infect Dis. 2018;66:306–11. 10.1093/cid/cix744 - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention. Candida auris (C. auris). Preventing the spread of C. auris. 2024. [cited 2025 Jan 28]. https://www.cdc.gov/candida-auris/prevention/index.html
    1. Rossow J, Ostrowsky B, Adams E, Greenko J, McDonald R, Vallabhaneni S, et al. ; New York Candida auris Investigation Workgroup. New York Candida auris Investigation Workgroup. Factors associated with Candida auris colonization and transmission in skilled nursing facilities with ventilator units, New York, 2016–2018. Clin Infect Dis. 2021;72:e753–60. 10.1093/cid/ciaa1462 - DOI - PMC - PubMed
    1. Adams E, Quinn M, Tsay S, Poirot E, Chaturvedi S, Southwick K, et al. ; Candida auris Investigation Workgroup. Candida auris Investigation Workgroup. Candida auris in healthcare facilities, New York, USA, 2013–2017. Emerg Infect Dis. 2018;24:1816–24. 10.3201/eid2410.180649 - DOI - PMC - PubMed
    1. Kerins JL, Tang AS, Forsberg K, Jegede O, Ealy M, Pacilli M, et al. Rapid emergence of Candida auris in the Chicago region. Open Forum Infect Dis. 2018;5(suppl_1):S28. 10.1093/ofid/ofy209.064 - DOI

MeSH terms

LinkOut - more resources